Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000337·INOVIO PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock · CUSIP: 45773H409
Event date: 2025-11-28
- Filing-level shares
- 6,666,295
- Percent of class
- 9.99%
- JANUS HENDERSON GROUP PLC
Shares: 6,666,295 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000337
- Form type
- SCHEDULE 13G/A
- Filer
- INOVIO PHARMACEUTICALS, INC.
- CIK
- CIK 1055726
- Filed
- Dec 08, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership